For decades, taking low-dose aspirin (81 mg) every day was widely recommended ... Yet 57 percent of people ages 50 to 80 who regularly take low-dose aspirin probably won’t benefit from it ...
An open-label clinical trial was conducted to compare the effects of aspirin 50 mg/day plus ticlopidine 200 mg/day, aspirin 50 mg/day plus dipyridamole 150 mg/day, and each agent as monotherapy ...
The most commonly recommended drug regimens include acetylsalicylic acid (aspirin), 50 325 mg daily (Albers et al., 1999; Wolf et al., 1999); ticlopidine (Ticlid), 250 mg twice daily (Albers ...
In this video, Michael Cecchini, MD, discussed data from the ALASCCA trial, which followed patients with colorectal cancer who were treated with a large dose of aspirin.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback